Status:
COMPLETED
Posterior cerebraL ArTery Occlusion Study
Lead Sponsor:
Boston Medical Center
Collaborating Sponsors:
Heidelberg University
Conditions:
Stroke, Acute Ischemic
Eligibility:
All Genders
18-89 years
Brief Summary
For this retrospective study, the investigators will collect and analyze data of patients who presented with posterior artery occlusion and underwent mechanical thrombectomy (the type of endovascular ...
Detailed Description
The primary aims of the research are to evaluate, in patients presenting with posterior artery occlusion (PCA), whether favorable outcome would be superior for EVT compared to Medically Management (MM...
Eligibility Criteria
Inclusion
- Had an ischemic stroke with isolated posterior cerebral artery occlusion (P1, P2, or P3 segments) and was medically managed or managed with EVT during the study time period.
Exclusion
- Patient with documented basilar artery occlusion and concomitant PCA occlusion
- Patient with documented basilar artery occlusion, migration with secondary PCA occlusion
Key Trial Info
Start Date :
January 5 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 31 2023
Estimated Enrollment :
1282 Patients enrolled
Trial Details
Trial ID
NCT05291637
Start Date
January 5 2022
End Date
January 31 2023
Last Update
June 4 2024
Active Locations (22)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Miami
Miami, Florida, United States, 33124
2
Miami Baptist Health
Miami, Florida, United States, 33176
3
Emory University School of Medicine
Atlanta, Georgia, United States, 30322
4
Boston Medical Center
Boston, Massachusetts, United States, 02118